All Book articles – Page 2
-
Book
The role of telehealth during the COVID-19 pandemic
The pandemic has driven the demand for telehealth services
-
Book
SARS-CoV-2 genomics and host cellular susceptibility factors of COVID-19
The genomics and genetics of SARS-CoV-2, its replication, and host cellular factors necessary for the viral entry into the host cell to cause the infection and further disease development.
-
Book
Neurological manifestations in COVID-19
A variety of disorders of the central nervous system and/or peripheral nervous system have been reported due to SARS-CoV-2 infection either as an early or delayed manifestation.
-
Book
Profiling some plant-based immunomodulatory bioactive compounds for COVID-19 prophylaxis and treatment based on Indian traditional medicine
Traditional medicines, alongside the ongoing therapeutic system, have the potential to provide effective treatments, improving the synergistic effects and prioritization of plant-based bioactive compounds in combating SARS-CoV-2
-
Book
COVID-19 prevention
A summary of the preventive measures and the evidentiary base for those relatively few strategies that have been subjected to empirical testing
-
Book
A trend analysis of the COVID-19 pandemic in Turkey
Examining country case studies, in this case Turkey (which has handled the pandemic effectively), to understand patterns is extremely important to strengthen the fight against the pandemic.
-
Book
The Swedish approach to Covid-19
An overview of the Swedish response to the pandemic, which differed greatly from many other countries
-
Book
New Zealand’s response to the first wave of COVID-19
An outline of the key features of New Zealand’s experience of the initial response to prevent entry, detect and limit the spread of COVID-19 in the country
-
Book
Vaccination and vaccines for COVID-19
An overview of vaccination and vaccine development historically and in the context of the COVID-19, including a summay of the biology and immune response demonstrated from previous coronavirus infections and SARS-CoV-2 and the challenges associated with vaccine production in a pandemic.
- Previous Page
- Page1
- Page2
- Next Page